Product
[203Pb]VMT-α-NET
1 clinical trial
2 indications
Indication
Neuroendocrine TumorIndication
Neuroendocrine Tumor Grade 1Clinical trial
A Phase 0 First-in-human Clinical Trial of [203Pb]VMT-α-NET SPECT/CT for Somatostatin Receptor Imaging of Neuroendocrine TumorsStatus: , Estimated PCD: 2025-09-01